4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-264382
Options or other derivatives
- Director acquired 13,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Behbahani Ali Director | 2026-06-05 | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | D | ||
Loading xslF345X06/ownership.xml…